COVID-19 Impact on Global Follicular Lymphoma Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 128 pages | ID: C2AA839DC7B3EN
QYResearch

Abstracts

This report focuses on the global Follicular Lymphoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Follicular Lymphoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Celgene Corporation
• Celldex Therapeutics, Inc.
• Celltrion, Inc.
• Cellular Biomedicine Group, Inc.
• Coherus BioSciences, Inc.
• CTI BioPharma Corp.
• Curis, Inc.
• Dynavax Technologies Corporation
• Eisai
• EpiZyme, Inc.
• F. Hoffmann-La Roche Ltd.
• Genentech, Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline Plc
• Hutchison MediPharma Limited
• Immune Design Corp.
• ImmunoGen, Inc.

Market segment by Type, the product can be split into

• Chemotherapy
• Radiotherapy
• Monoclonal Antibodies
• Stem Cell Transplantation

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Follicular Lymphoma Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Follicular Lymphoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Follicular Lymphoma Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Follicular Lymphoma Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chemotherapy
  1.4.3 Radiotherapy
  1.4.4 Monoclonal Antibodies
  1.4.5 Stem Cell Transplantation
1.5 Market by Application
  1.5.1 Global Follicular Lymphoma Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Follicular Lymphoma Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Follicular Lymphoma Treatment Industry
    1.6.1.1 Follicular Lymphoma Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Follicular Lymphoma Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Follicular Lymphoma Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Follicular Lymphoma Treatment Market Perspective (2015-2026)
2.2 Follicular Lymphoma Treatment Growth Trends by Regions
  2.2.1 Follicular Lymphoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Follicular Lymphoma Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Follicular Lymphoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Follicular Lymphoma Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Follicular Lymphoma Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Follicular Lymphoma Treatment Players by Market Size
  3.1.1 Global Top Follicular Lymphoma Treatment Players by Revenue (2015-2020)
  3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Follicular Lymphoma Treatment Market Concentration Ratio
  3.2.1 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Treatment Revenue in 2019
3.3 Follicular Lymphoma Treatment Key Players Head office and Area Served
3.4 Key Players Follicular Lymphoma Treatment Product Solution and Service
3.5 Date of Enter into Follicular Lymphoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Follicular Lymphoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2021-2026)

5 FOLLICULAR LYMPHOMA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Follicular Lymphoma Treatment Market Size by Application (2015-2020)
5.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Follicular Lymphoma Treatment Market Size (2015-2020)
6.2 Follicular Lymphoma Treatment Key Players in North America (2019-2020)
6.3 North America Follicular Lymphoma Treatment Market Size by Type (2015-2020)
6.4 North America Follicular Lymphoma Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Follicular Lymphoma Treatment Market Size (2015-2020)
7.2 Follicular Lymphoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Follicular Lymphoma Treatment Market Size by Type (2015-2020)
7.4 Europe Follicular Lymphoma Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Follicular Lymphoma Treatment Market Size (2015-2020)
8.2 Follicular Lymphoma Treatment Key Players in China (2019-2020)
8.3 China Follicular Lymphoma Treatment Market Size by Type (2015-2020)
8.4 China Follicular Lymphoma Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Follicular Lymphoma Treatment Market Size (2015-2020)
9.2 Follicular Lymphoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Follicular Lymphoma Treatment Market Size by Type (2015-2020)
9.4 Japan Follicular Lymphoma Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Follicular Lymphoma Treatment Market Size (2015-2020)
10.2 Follicular Lymphoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Follicular Lymphoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Follicular Lymphoma Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Follicular Lymphoma Treatment Market Size (2015-2020)
11.2 Follicular Lymphoma Treatment Key Players in India (2019-2020)
11.3 India Follicular Lymphoma Treatment Market Size by Type (2015-2020)
11.4 India Follicular Lymphoma Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Follicular Lymphoma Treatment Market Size (2015-2020)
12.2 Follicular Lymphoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Follicular Lymphoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Follicular Lymphoma Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Boehringer Ingelheim GmbH
  13.1.1 Boehringer Ingelheim GmbH Company Details
  13.1.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
  13.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
  13.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2015-2020))
  13.1.5 Boehringer Ingelheim GmbH Recent Development
13.2 Bristol-Myers Squibb Company
  13.2.1 Bristol-Myers Squibb Company Company Details
  13.2.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
  13.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.2.5 Bristol-Myers Squibb Company Recent Development
13.3 Celgene Corporation
  13.3.1 Celgene Corporation Company Details
  13.3.2 Celgene Corporation Business Overview and Its Total Revenue
  13.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
  13.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.3.5 Celgene Corporation Recent Development
13.4 Celldex Therapeutics, Inc.
  13.4.1 Celldex Therapeutics, Inc. Company Details
  13.4.2 Celldex Therapeutics, Inc. Business Overview and Its Total Revenue
  13.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
  13.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.4.5 Celldex Therapeutics, Inc. Recent Development
13.5 Celltrion, Inc.
  13.5.1 Celltrion, Inc. Company Details
  13.5.2 Celltrion, Inc. Business Overview and Its Total Revenue
  13.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
  13.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.5.5 Celltrion, Inc. Recent Development
13.6 Cellular Biomedicine Group, Inc.
  13.6.1 Cellular Biomedicine Group, Inc. Company Details
  13.6.2 Cellular Biomedicine Group, Inc. Business Overview and Its Total Revenue
  13.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
  13.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.6.5 Cellular Biomedicine Group, Inc. Recent Development
13.7 Coherus BioSciences, Inc.
  13.7.1 Coherus BioSciences, Inc. Company Details
  13.7.2 Coherus BioSciences, Inc. Business Overview and Its Total Revenue
  13.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
  13.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.7.5 Coherus BioSciences, Inc. Recent Development
13.8 CTI BioPharma Corp.
  13.8.1 CTI BioPharma Corp. Company Details
  13.8.2 CTI BioPharma Corp. Business Overview and Its Total Revenue
  13.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
  13.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.8.5 CTI BioPharma Corp. Recent Development
13.9 Curis, Inc.
  13.9.1 Curis, Inc. Company Details
  13.9.2 Curis, Inc. Business Overview and Its Total Revenue
  13.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
  13.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.9.5 Curis, Inc. Recent Development
13.10 Dynavax Technologies Corporation
  13.10.1 Dynavax Technologies Corporation Company Details
  13.10.2 Dynavax Technologies Corporation Business Overview and Its Total Revenue
  13.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
  13.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  13.10.5 Dynavax Technologies Corporation Recent Development
13.11 Eisai
  10.11.1 Eisai Company Details
  10.11.2 Eisai Business Overview and Its Total Revenue
  10.11.3 Eisai Follicular Lymphoma Treatment Introduction
  10.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.11.5 Eisai Recent Development
13.12 EpiZyme, Inc.
  10.12.1 EpiZyme, Inc. Company Details
  10.12.2 EpiZyme, Inc. Business Overview and Its Total Revenue
  10.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
  10.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.12.5 EpiZyme, Inc. Recent Development
13.13 F. Hoffmann-La Roche Ltd.
  10.13.1 F. Hoffmann-La Roche Ltd. Company Details
  10.13.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  10.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
  10.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.13.5 F. Hoffmann-La Roche Ltd. Recent Development
13.14 Genentech, Inc.
  10.14.1 Genentech, Inc. Company Details
  10.14.2 Genentech, Inc. Business Overview and Its Total Revenue
  10.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
  10.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.14.5 Genentech, Inc. Recent Development
13.15 Gilead Sciences, Inc.
  10.15.1 Gilead Sciences, Inc. Company Details
  10.15.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
  10.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
  10.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.15.5 Gilead Sciences, Inc. Recent Development
13.16 GlaxoSmithKline Plc
  10.16.1 GlaxoSmithKline Plc Company Details
  10.16.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  10.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
  10.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.16.5 GlaxoSmithKline Plc Recent Development
13.17 Hutchison MediPharma Limited
  10.17.1 Hutchison MediPharma Limited Company Details
  10.17.2 Hutchison MediPharma Limited Business Overview and Its Total Revenue
  10.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
  10.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.17.5 Hutchison MediPharma Limited Recent Development
13.18 Immune Design Corp.
  10.18.1 Immune Design Corp. Company Details
  10.18.2 Immune Design Corp. Business Overview and Its Total Revenue
  10.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
  10.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.18.5 Immune Design Corp. Recent Development
13.19 ImmunoGen, Inc.
  10.19.1 ImmunoGen, Inc. Company Details
  10.19.2 ImmunoGen, Inc. Business Overview and Its Total Revenue
  10.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
  10.19.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020)
  10.19.5 ImmunoGen, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Follicular Lymphoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Follicular Lymphoma Treatment Revenue
Table 3. Ranking of Global Top Follicular Lymphoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Follicular Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Monoclonal Antibodies
Table 8. Key Players of Stem Cell Transplantation
Table 9. COVID-19 Impact Global Market: (Four Follicular Lymphoma Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Follicular Lymphoma Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Follicular Lymphoma Treatment Players to Combat Covid-19 Impact
Table 14. Global Follicular Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Follicular Lymphoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Follicular Lymphoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Follicular Lymphoma Treatment Market Share by Regions (2015-2020)
Table 18. Global Follicular Lymphoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Follicular Lymphoma Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Follicular Lymphoma Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Follicular Lymphoma Treatment Players
Table 25. Global Follicular Lymphoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Follicular Lymphoma Treatment Market Share by Players (2015-2020)
Table 27. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2019)
Table 28. Global Follicular Lymphoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Follicular Lymphoma Treatment Product Solution and Service
Table 31. Date of Enter into Follicular Lymphoma Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Follicular Lymphoma Treatment Market Size Share by Type (2015-2020)
Table 35. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Follicular Lymphoma Treatment Market Size Share by Application (2015-2020)
Table 37. Global Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Follicular Lymphoma Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 41. North America Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 43. North America Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 47. Europe Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 49. Europe Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 53. China Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 55. China Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 59. Japan Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 61. Japan Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 65. Southeast Asia Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 71. India Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 73. India Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Follicular Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Follicular Lymphoma Treatment Market Share (2019-2020)
Table 77. Central & South America Follicular Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Follicular Lymphoma Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Follicular Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Follicular Lymphoma Treatment Market Share by Application (2015-2020)
Table 81. Boehringer Ingelheim GmbH Company Details
Table 82. Boehringer Ingelheim GmbH Business Overview
Table 83. Boehringer Ingelheim GmbH Product
Table 84. Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 85. Boehringer Ingelheim GmbH Recent Development
Table 86. Bristol-Myers Squibb Company Company Details
Table 87. Bristol-Myers Squibb Company Business Overview
Table 88. Bristol-Myers Squibb Company Product
Table 89. Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 90. Bristol-Myers Squibb Company Recent Development
Table 91. Celgene Corporation Company Details
Table 92. Celgene Corporation Business Overview
Table 93. Celgene Corporation Product
Table 94. Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 95. Celgene Corporation Recent Development
Table 96. Celldex Therapeutics, Inc. Company Details
Table 97. Celldex Therapeutics, Inc. Business Overview
Table 98. Celldex Therapeutics, Inc. Product
Table 99. Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 100. Celldex Therapeutics, Inc. Recent Development
Table 101. Celltrion, Inc. Company Details
Table 102. Celltrion, Inc. Business Overview
Table 103. Celltrion, Inc. Product
Table 104. Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 105. Celltrion, Inc. Recent Development
Table 106. Cellular Biomedicine Group, Inc. Company Details
Table 107. Cellular Biomedicine Group, Inc. Business Overview
Table 108. Cellular Biomedicine Group, Inc. Product
Table 109. Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 110. Cellular Biomedicine Group, Inc. Recent Development
Table 111. Coherus BioSciences, Inc. Company Details
Table 112. Coherus BioSciences, Inc. Business Overview
Table 113. Coherus BioSciences, Inc. Product
Table 114. Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 115. Coherus BioSciences, Inc. Recent Development
Table 116. CTI BioPharma Corp. Business Overview
Table 117. CTI BioPharma Corp. Product
Table 118. CTI BioPharma Corp. Company Details
Table 119. CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 120. CTI BioPharma Corp. Recent Development
Table 121. Curis, Inc. Company Details
Table 122. Curis, Inc. Business Overview
Table 123. Curis, Inc. Product
Table 124. Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 125. Curis, Inc. Recent Development
Table 126. Dynavax Technologies Corporation Company Details
Table 127. Dynavax Technologies Corporation Business Overview
Table 128. Dynavax Technologies Corporation Product
Table 129. Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 130. Dynavax Technologies Corporation Recent Development
Table 131. Eisai Company Details
Table 132. Eisai Business Overview
Table 133. Eisai Product
Table 134. Eisai Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 135. Eisai Recent Development
Table 136. EpiZyme, Inc. Company Details
Table 137. EpiZyme, Inc. Business Overview
Table 138. EpiZyme, Inc. Product
Table 139. EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 140. EpiZyme, Inc. Recent Development
Table 141. F. Hoffmann-La Roche Ltd. Company Details
Table 142. F. Hoffmann-La Roche Ltd. Business Overview
Table 143. F. Hoffmann-La Roche Ltd. Product
Table 144. F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 145. F. Hoffmann-La Roche Ltd. Recent Development
Table 146. Genentech, Inc. Company Details
Table 147. Genentech, Inc. Business Overview
Table 148. Genentech, Inc. Product
Table 149. Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 150. Genentech, Inc. Recent Development
Table 151. Gilead Sciences, Inc. Company Details
Table 152. Gilead Sciences, Inc. Business Overview
Table 153. Gilead Sciences, Inc. Product
Table 154. Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 155. Gilead Sciences, Inc. Recent Development
Table 156. GlaxoSmithKline Plc Company Details
Table 157. GlaxoSmithKline Plc Business Overview
Table 158. GlaxoSmithKline Plc Product
Table 159. GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 160. GlaxoSmithKline Plc Recent Development
Table 161. Hutchison MediPharma Limited Company Details
Table 162. Hutchison MediPharma Limited Business Overview
Table 163. Hutchison MediPharma Limited Product
Table 164. Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 165. Hutchison MediPharma Limited Recent Development
Table 166. Immune Design Corp. Company Details
Table 167. Immune Design Corp. Business Overview
Table 168. Immune Design Corp. Product
Table 169. Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 170. Immune Design Corp. Recent Development
Table 171. ImmunoGen, Inc. Company Details
Table 172. ImmunoGen, Inc. Business Overview
Table 173. ImmunoGen, Inc. Product
Table 174. ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2015-2020) (Million US$)
Table 175. ImmunoGen, Inc. Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Follicular Lymphoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Stem Cell Transplantation Features
Figure 6. Global Follicular Lymphoma Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Follicular Lymphoma Treatment Report Years Considered
Figure 11. Global Follicular Lymphoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Follicular Lymphoma Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Follicular Lymphoma Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Follicular Lymphoma Treatment Market Share by Players in 2019
Figure 16. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Follicular Lymphoma Treatment Revenue in 2019
Figure 18. North America Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Follicular Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Boehringer Ingelheim GmbH Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 27. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bristol-Myers Squibb Company Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 29. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Celgene Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 31. Celldex Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Celldex Therapeutics, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 33. Celltrion, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Celltrion, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 35. Cellular Biomedicine Group, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 37. Coherus BioSciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Coherus BioSciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 39. CTI BioPharma Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. CTI BioPharma Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 41. Curis, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Curis, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 43. Dynavax Technologies Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Dynavax Technologies Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 45. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Eisai Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 47. EpiZyme, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. EpiZyme, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 49. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 51. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Genentech, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 53. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Gilead Sciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 55. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. GlaxoSmithKline Plc Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 57. Hutchison MediPharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hutchison MediPharma Limited Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 59. Immune Design Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Immune Design Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 61. ImmunoGen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. ImmunoGen, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed